以岭药业(002603.SZ)：盐酸美金刚收到化学原料药上市申请批准通知书

Core Viewpoint - Yiling Pharmaceutical (002603.SZ) announced that its wholly-owned subsidiary, Wanyang Hengshui Pharmaceutical Co., Ltd., has received the approval notice for the listing application of the chemical raw material drug Memantine Hydrochloride from the National Medical Products Administration [1] Company Summary - The approved drug, Memantine Hydrochloride, is a voltage-dependent, moderate-affinity non-competitive NMDA receptor antagonist [1] - Memantine Hydrochloride is used to block neuronal damage caused by pathological increases in glutamate concentration, specifically for the treatment of moderate to severe Alzheimer's disease [1]